Compounds > haloperidol

haloperidol and sr 48692

haloperidol has been researched along with sr 48692 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dix, TA; Hadden, MK; Lassetter, MR; Orwig, KS	1
Gully, D; Le Fur, G; Mons, G; Rodier, D; Soubrié, P; Steinberg, R	1
Gross, R; Kilts, CD; Lambert, PD; Nemeroff, CB	1
Brun, P; Le Fur, G; Soubrié, P; Steinberg, R	1
Cheung, S; Hentschel, K; Lookingland, KJ; Moore, KE	1
Gueudet, C; Michaud, JC; Soubrié, P	1
Deutch, AY; Dobner, PR; Fadel, J	1
Brun, P; Leonetti, M; Renaud, B; Sotty, F; Soubrié, P; Steinberg, R; Suaud-Chagny, MF	1
Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S	1
Chartoff, EH; Dorsa, DM; Palmiter, RD; Szczypka, MS	1

Reviews

1 review(s) available for haloperidol and sr 48692

Article	Year
Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system. Annals of the New York Academy of Sciences, 1995, May-10, Volume: 757 Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Cyclic AMP; Dopamine; Haloperidol; Neurotensin; Pyrazoles; Quinolines; Receptors, Dopamine; Receptors, Neurotensin; Schizophrenia; Signal Transduction	1995

Other Studies

9 other study(ies) available for haloperidol and sr 48692

Article	Year
Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. Journal of medicinal chemistry, 2009, Apr-09, Volume: 52, Issue:7 Topics: Aminopeptidases; Animals; Binding, Competitive; Body Temperature; Calcium; Cell Line; Humans; In Vitro Techniques; Intracellular Space; Male; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Structure-Activity Relationship	2009
SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum. Neuropeptides, 1995, Volume: 29, Issue:1 Topics: Acetylcholine; Animals; Corpus Striatum; Haloperidol; Male; Microdialysis; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin	1995
Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. Journal of neurochemistry, 1995, Volume: 64, Issue:5 Topics: Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Electrodes; Haloperidol; Kainic Acid; Male; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin	1995
Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons. Neuroendocrinology, 1998, Volume: 68, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Binding, Competitive; Dopamine; Dopamine Antagonists; Female; Haloperidol; Male; Median Eminence; Neurons; Neurotensin; Prolactin; Pyrazoles; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotensin; Sex Factors	1998
Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons. Neuroreport, 2000, May-15, Volume: 11, Issue:7 Topics: Action Potentials; Animals; Clozapine; Dopamine Antagonists; Electrophysiology; Globus Pallidus; Haloperidol; Male; Neurons; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Serotonin Antagonists	2000
The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat. Neuroscience letters, 2001, Apr-27, Volume: 303, Issue:1 Topics: Animals; Corpus Striatum; Dopamine Antagonists; Gene Expression; Genes, fos; Haloperidol; Male; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin	2001
Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist. Journal of neurochemistry, 2001, Volume: 77, Issue:6 Topics: Adamantane; Animals; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Electrochemistry; Haloperidol; Imidazoles; Male; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stimulation, Chemical	2001
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice. Neuropharmacology, 2004, Volume: 47, Issue:1 Topics: Adamantane; Analysis of Variance; Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Imidazoles; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyrazoles; Quinolines; Receptors, Neurotensin	2004
Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. Brain research, 2004, Oct-01, Volume: 1022, Issue:1-2 Topics: Age Factors; Animals; Behavior, Animal; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Gene Expression; Haloperidol; In Situ Hybridization; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Messenger; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase	2004